Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate - PubMed
- ️Invalid Date
. 1997 Mar;280(3):1383-91.
Affiliations
- PMID: 9067327
Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate
J M Rho et al. J Pharmacol Exp Ther. 1997 Mar.
Abstract
Felbamate and meprobamate are structurally related propanediol dicarbamates that possess distinct pharmacological profiles. Felbamate is a minimally sedative, broad-spectrum anticonvulsant, whereas meprobamate is a strong sedative-anxiolytic agent. Previously, we reported that felbamate potentiates gamma-aminobutyric acid(A) (GABA(A)) receptor Cl- currents and inhibits N-methyl-D-aspartate (NMDA) receptor currents. Here we further characterized the interaction of the two dicarbamates with GABA(A) receptors to determine the basis for their pharmacological differences. In whole-cell voltage-clamp recordings from cultured rat hippocampal neurons, meprobamate enhanced GABA-evoked responses in a concentration-dependent manner and, at high concentrations (>1 mM), exhibited a separate channel-blocking effect that limited the magnitude of GABA(A) receptor potentiation. At equivalent concentrations, meprobamate produced substantially greater potentiation than did felbamate. Furthermore, meprobamate (but not felbamate), in the absence of GABA, directly activated Cl- currents that could be attenuated by the GABA(A) receptor antagonists bicuculline and picrotoxin. The mean deactivation time constant of whole-cell currents evoked by 10 mM meprobamate (110 ms) or 1 and 3 microM GABA (180 ms) were faster than the deactivation time constant of 10 mM meprobamate (490 ms) or 3 mM felbamate (470 ms) in the presence of GABA. Meprobamate and felbamate prolonged the mean burst duration of GABA-activated unitary currents in excised outside-out membrane patches. In addition, at high (supratherapeutic) concentrations, meprobamate blocked NMDA-activated currents. We conclude that felbamate and meprobamate have barbiturate-like modulatory actions on GABA(A) receptors, but meprobamate has greater activity and, unlike felbamate, is able to directly activate the receptor.
Similar articles
-
Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons.
Rho JM, Donevan SD, Rogawski MA. Rho JM, et al. J Physiol. 1996 Dec 1;497 ( Pt 2)(Pt 2):509-22. doi: 10.1113/jphysiol.1996.sp021784. J Physiol. 1996. PMID: 8961191 Free PMC article.
-
Rho JM, Donevan SD, Rogawski MA. Rho JM, et al. Ann Neurol. 1994 Feb;35(2):229-34. doi: 10.1002/ana.410350216. Ann Neurol. 1994. PMID: 8109904
-
Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP, Rogawski MA. Subramaniam S, et al. J Pharmacol Exp Ther. 1995 May;273(2):878-86. J Pharmacol Exp Ther. 1995. PMID: 7752093
-
The pharmacology of propanediol carbamates.
Ludwig BJ, Potterfield JR. Ludwig BJ, et al. Adv Pharmacol Chemother. 1971;9:173-240. doi: 10.1016/s1054-3589(08)60447-0. Adv Pharmacol Chemother. 1971. PMID: 4949460 Review. No abstract available.
-
[No authors listed] [No authors listed] 2020 Jan 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Jan 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644030 Free Books & Documents. Review.
Cited by
-
Greenhill SD, Jones RS. Greenhill SD, et al. Neuroscience. 2010 May 5;167(2):456-74. doi: 10.1016/j.neuroscience.2010.02.021. Epub 2010 Feb 16. Neuroscience. 2010. PMID: 20167261 Free PMC article.
-
Whalley BJ, Stephens GJ, Constanti A. Whalley BJ, et al. Br J Pharmacol. 2009 Mar;156(6):994-1008. doi: 10.1111/j.1476-5381.2008.00110.x. Br J Pharmacol. 2009. PMID: 19226287 Free PMC article.
-
Something old, something new: a successful case of meprobamate withdrawal.
James AO, Nicholson TR, Hill R, Bearn J. James AO, et al. BMJ Case Rep. 2016 Feb 29;2016:bcr2015213606. doi: 10.1136/bcr-2015-213606. BMJ Case Rep. 2016. PMID: 26929223 Free PMC article.
-
Carbonaro TM, Nguyen V, Forster MJ, Gatch MB, Prokai L. Carbonaro TM, et al. Neuropharmacology. 2020 Sep 1;174:108152. doi: 10.1016/j.neuropharm.2020.108152. Epub 2020 May 29. Neuropharmacology. 2020. PMID: 32479814 Free PMC article.
-
Matošević A, Bosak A. Matošević A, et al. Arh Hig Rada Toksikol. 2020 Dec 31;71(4):285-299. doi: 10.2478/aiht-2020-71-3466. Arh Hig Rada Toksikol. 2020. PMID: 33410773 Free PMC article. Review.